We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases,... Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Show more
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.23 | -4.7520661157 | 4.84 | 4.84 | 4.15 | 3303160 | 4.43039892 | CS |
4 | -1.01 | -17.9715302491 | 5.62 | 6.11 | 4.15 | 3273411 | 5.05043733 | CS |
12 | -1.39 | -23.1666666667 | 6 | 6.43 | 4.15 | 3054320 | 5.30323096 | CS |
26 | -2.69 | -36.8493150685 | 7.3 | 9.97 | 4.15 | 3210962 | 6.25987377 | CS |
52 | 2.05 | 80.078125 | 2.56 | 9.97 | 2.43 | 2191732 | 5.71565912 | CS |
156 | -5.59 | -54.8039215686 | 10.2 | 11.34 | 1.96 | 1024819 | 5.29815736 | CS |
260 | -5.39 | -53.9 | 10 | 17.45 | 1.96 | 976823 | 5.49466365 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions